drugset / Trial / NCT03806790
Efficacy and Safety of LEO 90100 Foam in Japanese Subjects With Psoriasis Vulgaris
RandomizedParallel-groupOpen-labelTreatment
Summary
Comparison of the efficacy of LEO 90100 foam with Dovobet® ointment in the treatment of psoriasis in Japanese subjects.
Timeline
- Start
- 2019-01-24
- Primary completion
- 2019-06-10
- Completion
- 2019-06-10
Outcome
Missed primary endpoint
registry analysis (superiority test); LEO 90100 Foam vs Dovobet® Ointment; p = 0.120; Odds Ratio (OR) 5.80 (95% CI 0.68 to 49.16); Fisher Exact NCT03806790 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Calcipotriene | Other / unclassified | — | Topical |
| Comparator | betamethasone dipropionate | Small molecule | — | Topical |